Intraventricular pressure gradients change during the development of left ventricular hypertrophy: Effect of salvianolic acid B and beta-blocker.
Danfu MaAhmed S MandourTomihiko YoshidaKatsuhiro MatsuuraKazumi ShimadaPitipat KitpipatkunAkiko UemuraMayumi IfukuKen TakahashiRyou TanakaPublished in: Ultrasound (Leeds, England) (2021)
Salvianolic acid B and Carvedilol promote cardiac function by decreasing the elevated basal intraventricular pressure gradient. The current preclinical results revealed the efficacy of salvianolic acid B as a potential therapy for left ventricular hypertrophy because of the non-blood pressure lowering effect.
Keyphrases
- left ventricular
- blood pressure
- heart failure
- acute myocardial infarction
- hypertrophic cardiomyopathy
- aortic stenosis
- mitral valve
- type diabetes
- stem cells
- single cell
- heart rate
- left atrial
- coronary artery disease
- adipose tissue
- transcatheter aortic valve replacement
- atrial fibrillation
- hypertensive patients
- acute coronary syndrome
- angiotensin ii
- metabolic syndrome
- human health
- catheter ablation